Globus Medical Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Truist Securities Reiterates Hold Rating on Globus Medical (GMED)
February 24, 2025 2:46 PM ESTTruist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED)
The analyst comments "GMED's relatively broad/clean 4Q beat was somewhat clouded by ongoing q's re: the unexpected NVRO deal (announced 2/6 [HERE]). We think... More
